Vetnostrum Animal Health Co., Ltd. (TPE:6936)

Market Cap	2.63B +8.5%
Revenue (ttm)	1.37B +11.8%
Net Income	119.57M +10.1%
EPS	1.72 +5.8%
Shares Out	72.76M
PE Ratio	20.94
Forward PE	n/a
Dividend	1.69 (4.67%)
Ex-Dividend Date	Jul 16, 2025

Volume	35,225
Average Volume	61,695
Open	36.10
Previous Close	36.15
Day's Range	35.90 - 36.10
52-Week Range	34.00 - 51.10
Beta	0.08
RSI	56.57
Earnings Date	Mar 25, 2026

About Vetnostrum Animal Health

Vetnostrum Animal Health Co., Ltd. engages in the production and sale of animal health products in Taiwan and the Asia Pacific. It offers antibiotics, hormonal preparations, topical disinfectants, and drugs for anti-inflammatory, deworming, anti-fungal, antiprotozoal, etc; vitamins, minerals, and amino acids for regular supplementary; and non-medicated feed additives for swine, cattle and sheep, poultry, pet, and aquatic animals. The company is based in Taichung, Taiwan. Vetnostrum Animal Health Co., Ltd. operates as a subsidiary of YungShin Gl...

• Industry: Farm Products
• Sector: Consumer Staples
• CEO: Wei-Kai Chung
• Employees: 170
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6936

Financial Performance

In 2024, Vetnostrum Animal Health's revenue was 1.29 billion, an increase of 7.17% compared to the previous year's 1.21 billion. Earnings were 136.62 million, an increase of 49.15%.